TABLE 4.
MIC data for Australian clinical Elizabethkingia meningoseptica and Elizabethkingia miricola isolates against clinically relevant antimicrobials
MIC data derived from broth microdilution testing of the 2 E. meningoseptica (blue font) and 3 E. miricola (orange font) Australian clinical isolates against 39 clinically relevant antimicrobials. Pharmacokinetic-pharmacodynamic (non-species-specific) breakpoints applied from EUCAST Clinical Breakpoint Tables (version 9.0) are shown in columns with yellow shading, and non-Enterobacteriaceae breakpoints applied from CLSI M100-29 (2019) are shown in columns with blue shading. Shaded blue and yellow cells indicate that no breakpoint is currently available for this antimicrobial within these schemes. S, susceptible; I, susceptible with high exposure (EUCAST definition) or intermediate (CLSI definition); R, resistant.
Tazobactam concentration fixed at 4 mg/liter.
Clavulanic acid concentration fixed at 2 mg/liter.
Sulbactam concentration fixed at 4 mg/liter.